CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Income Statement [Abstract]
Net revenue
Cost of revenue
Gross profit
Selling expenses		345,845
Research and development expenses	149,971	565,801
General and administrative expenses	2,177,569	2,361,026
Total operating expenses	2,327,540	3,272,672
Operating loss	(2,327,540)	(3,272,672)
Other expenses		(1,415)
Loss before income taxes	(2,327,540)	(3,274,087)
Income taxes
Loss from continuing operations	(2,327,540)	(3,274,087)
Loss from discontinued operations		(61,204)
Net loss	$ (2,327,540)	$ (3,335,291)
Loss per common share from continuing operations - basic and diluted (in dollars per share)	$ (0.07)	$ (0.13)
Loss per common share from discontinued operations- basic and diluted (in dollars per share)
Loss per common share - basic and diluted (in dollars per share)	$ (0.07)	$ (0.13)
Weighted average shares outstanding, basic and diluted (in shares)	35,741,357	24,916,867